UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 1 filers reported holding UNIQURE NV in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,436 | +247.8% | 14,968 | +494.0% | 0.00% | +200.0% |
| Q2 2023 | $28,879 | +17297.0% | 2,520 | -69.4% | 0.00% | -80.0% |
| Q1 2023 | $166 | -37.8% | 8,232 | -29.9% | 0.01% | -54.5% |
| Q4 2022 | $267 | -99.3% | 11,749 | +443.9% | 0.01% | +1000.0% |
| Q3 2022 | $40,000 | -81.9% | 2,160 | -81.8% | 0.00% | -80.0% |
| Q2 2022 | $221,000 | -34.4% | 11,860 | -36.4% | 0.01% | +66.7% |
| Q1 2022 | $337,000 | +180.8% | 18,639 | +223.4% | 0.00% | +50.0% |
| Q4 2021 | $120,000 | -30.2% | 5,763 | +7.1% | 0.00% | -50.0% |
| Q3 2021 | $172,000 | +514.3% | 5,382 | +484.4% | 0.00% | +300.0% |
| Q2 2021 | $28,000 | +86.7% | 921 | +110.8% | 0.00% | – |
| Q1 2021 | $15,000 | -96.5% | 437 | -96.3% | 0.00% | -100.0% |
| Q4 2020 | $432,000 | +1007.7% | 11,970 | +1032.5% | 0.01% | – |
| Q3 2020 | $39,000 | -33.9% | 1,057 | -19.1% | 0.00% | -100.0% |
| Q2 2020 | $59,000 | -53.2% | 1,306 | -25.6% | 0.00% | -80.0% |
| Q4 2019 | $126,000 | +4100.0% | 1,756 | +1990.5% | 0.01% | – |
| Q3 2019 | $3,000 | -96.2% | 84 | -93.6% | 0.00% | -100.0% |
| Q1 2019 | $78,000 | +3800.0% | 1,312 | +1673.0% | 0.01% | – |
| Q4 2018 | $2,000 | 0.0% | 74 | -80.2% | 0.00% | – |
| Q4 2016 | $2,000 | -94.1% | 374 | -91.5% | 0.00% | -100.0% |
| Q3 2016 | $34,000 | +3300.0% | 4,386 | +2093.0% | 0.00% | – |
| Q2 2016 | $1,000 | -96.6% | 200 | -91.7% | 0.00% | -100.0% |
| Q1 2016 | $29,000 | +866.7% | 2,415 | +1381.6% | 0.00% | – |
| Q4 2015 | $3,000 | -89.7% | 163 | -88.7% | 0.00% | -100.0% |
| Q3 2015 | $29,000 | +480.0% | 1,438 | +649.0% | 0.00% | +200.0% |
| Q1 2015 | $5,000 | +66.7% | 192 | -4.0% | 0.00% | – |
| Q4 2014 | $3,000 | -50.0% | 200 | -53.6% | 0.00% | -100.0% |
| Q2 2014 | $6,000 | – | 431 | +43000.0% | 0.00% | – |
| Q1 2014 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |